Latest ArticlesIn order to control the product quality of loratadine(1) orodispersible films and provide references for the establishment of specification for similar dosage forms, a quality standard for 1 orodispersible films had been established based on the guidance principles issued by ICH and NMPA, and referring to the pharmacopoeia standards of 1 oral solid dosage forms and the quality information on orodispersible films marketed abroad, in combination with the characteristics of 1 orodispersible films. Quality inspection and stability investigation of three batches of 1 orodispersible films were carried out. The results showed that the appearance, identification, related substances, dissolution, disintegration time, content, content uniformity and microbial limits of the self-made 1 orodispersible films were in compliance with the quality standard, indicating that the self-made product had good stability. In conclusion, the quality standard provided could adequately control the product quality of 1 orodispersible films.
A liquid chromatography coupled to tandem mass spectrometry(LC-MS/MS) method was established for determination of aripiprazole in Beagle dog plasma with diphenhydramine as the internal standard. The detection was conducted with an electrospray ionization(ESI) interface via multiple reaction monitoring(MRM) under positive ionization mode. It was linear for aripiprazole in the concentration range of 0.1 - 100 ng/mL. The method validation tests were carried out. The recoveries were 97.8% - 100.3%, and intra- and inter-day RSDs were respectively less than 3.80% and 6.97%. No significant matrix effects were observed and the analytes were proved to be stable. This validated method was applied to the pharmacokinetics study of the self-made aripiprazole orodispersible films and the commercially available aripiprazole orally disintegrating tablets in Beagle Dogs. The results exhibited the similar pharmacokinetic characteristics between these two dosage forms and the relative bioavailability of the self-made films was (110.1±10.5)%.
Based on the phase solubility determination results of clonidine in different cyclodextrin derivatives, methyl-β-cyclodextrin was screened out because of the high inclusion efficiency. Then the inclusion complexes with the inclusion ratio of methyl-β-cyclodextrin to clonidine of 1∶1 were prepared by rotary evaporation method. The drug loading and encapsulation rates of the inclusion complexes were (13.45±0.22)% and (88.78±0.56)%, respectively. After that, the orodispersible films based on the obtained inclusion complexes were prepared by cast coating method. The formulation compositions were optimized by single factor tests, and the results were as follows: PVA 5-88(80%), inclusion complex(4%), 1,2-propylene glycol(10%), and low-substituted hydroxypropyl cellulose(10%). The quality attributes of the optimized films were determined. The results showed that the thickness, water content, surface pH value, tensile strength and elongation at break of the self-made films were (91.72±1.74)µm, 4.71%, 6.75±0.09, (62.44±3.19)N/mm2, and (107.15±7.02)%, respectively. Finally, the taste masking effect was evaluated by the electronic tongue techniques. The results showed that the taste masking effect of the inclusion complex was better than that of aspartame. In conclusion, cyclodextrin inclusion technology can significantly mask the bitterness of a drug.
The orodispersible films(ODFs) of tandospirone citrate were prepared by solvent casting method. The film-forming materials, taste masking agent and plasticizer were screened and optimized by single factor tests. The optimal formulation was as follows: 10.8% of tandospirone citrate, 37.5% of HPMC E5, 7.5% of hydroxypropyl cellulose, 27.0% of hydroxypropyl-β-cyclodextrin, 15% of glycerin, and 2.2% of sucralose. The obtained ODFs had good film properties with a disintegration time of about 40 s. The requirements for content uniformity and related substances were met. The dissolution rate in water at 15 min exceeded 85%, which was similar to that of the commercially available tablets. The bitterness of the drug was well masked on the basis of the inclusion effect of hydroxypropyl-β-cyclodextrin. The stability tests were conducted under photolysis, high temperature, and high humidity conditions. The results showed that the ODFs had good stability except for high temperature at 60 ℃. The appearance, drug content and related substances of the ODFs stored under other conditions had not significantly changed. After being stored for one month under accelerated test condition(40 ℃ and 75% of relative humidity), the API crystal form remained stable.
The pharmacokinetic characteristics of domestically produced tadalafil(1) orodispersible films in healthy male Chinese volunteers and their relative bioavailability compared with tadalafil tablets were investigated. A randomized, open-label, 3-period, Latin square crossover trial under fasting conditions was performed, and 36 volunteers were randomized 1∶1∶1 to receive single oral dose of 1 film without water, 1 film or tablet with water. A randomized, open label, 2-period crossover trial under fed conditions was also performed, and 32 volunteers were randomized 1∶1 to receive 1 film or tablet with water. A LC-MS/MS method was used to determine the concentration of 1 in plasma. Main pharmacokinetic parameters were calculated by WinNonlin 8.1 software and the statistical analysis was conducted with SAS 9.4 software. The results showed that compared with 1 tablet, the 90% confidence intervals for the geometric mean ratios of the main pharmacokinetic parameters(cmax, AUC0→t and AUC0→∞) of the 1 film in the fasting state were within the range of 80% - 125%. While the 90% confidence interval for the geometric mean ratio of cmax of the 1 film was not within the range of 80% - 125% in the fed state. These results showed that 1 film(with or without water) was bioequivalent to 1 tablets under fasting conditions but not bioequivalent under fed conditions.
This research conducted a commissioning on the critical components of the film coating machine, by investigating the impact of the feeding height of casting mixture on thickness and weight variation of the blank films, the effect of casting height on film thickness and disintegration time, the influences of air flow rates at inlet and outlet on drying temperature, and the consistency of running speed. Three batches of tadalafil orodispersible films(ODFs) with 100 000 pieces per batch were prepared with the machine in a GMP workshop, and the casting process parameters were verified to evaluate the casting uniformity and stability of the equipment. The results showed that the heating temperature could be steadily controlled within the range of 30 - 120 ℃, the running speed could be accurately set within the range of 0.1 - 2.0 m/min and the deviations between the measured and set values were within ±1%. Additionally, the equipment offered a maximum output of approximately 480 000 pieces per 8 hours. The thickness of the three batches of ODFs was 60 - 64 µm, and weight variations of three batches were –2.06% to +1.37%, –3.34% to +2.68%, and –1.89% to+2.05%, respectively. There were no significant changes in the thickness and width of the films during the continuous operation of the equipment for 6 hours, and the films sampled from the front, middle and rear sections of the liner performed well on content uniformity with the values of A+2.2S ranging from 2.3 to 7.4. In conclusion, this equipment can basically meet the requirements of the industrial production for pharmaceutical films.